Liquid biopsy analyses of circulating tumor DNA are emerging as transformative tools for colorectal cancer management, enabling disease detection, monitoring, and treatment. Here, we critically assess its evidence-based utility in current clinical practice, seeking to align physicians’ and patients’ expectations.
Clinical utility and future perspectives of liquid biopsy in colorectal cancer
Patelli, Giorgio;Crisafulli, Giovanni;Bardelli, Alberto;
2025-01-01
Abstract
Liquid biopsy analyses of circulating tumor DNA are emerging as transformative tools for colorectal cancer management, enabling disease detection, monitoring, and treatment. Here, we critically assess its evidence-based utility in current clinical practice, seeking to align physicians’ and patients’ expectations.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2025-Clinical utility.pdf
Accesso aperto
Tipo di file:
PDF EDITORIALE
Dimensione
902.43 kB
Formato
Adobe PDF
|
902.43 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
